title: Menopause management: how you can do better.
abstract: Let patients know that hot flashes, vaginal dryness, and other common menopausal symptoms can be treated successfully with hormonal and nonhormonal agents.
authors.affiliation: Department of Family and Community Medicine, University of Kansas School of Medicine-Wichita, KS 67214, USA. gdickson@kumc.edu
authors.forename: Gretchen M
authors.initials: GM
authors.lastname: Dickson
mesh_terms: D015670:Acupuncture Therapy; D000276:Adjuvants, Immunologic / Q000627:therapeutic use; D000279:Administration, Cutaneous; D000287:Administration, Topical; D000339:Affect; D000367:Age Factors; D000726:Androgen Antagonists / Q000627:therapeutic use; D000728:Androgens / Q000627:therapeutic use; D000928:Antidepressive Agents / Q000627:therapeutic use; D018687:Antidepressive Agents, Second-Generation / Q000627:therapeutic use; D059268:Atrophic Vaginitis / Q000503:physiopathology / Q000628:therapy*; D053961:Azabicyclo Compounds / Q000627:therapeutic use; D016642:Bupropion / Q000627:therapeutic use; D017373:Cyproterone Acetate / Q000627:therapeutic use; D003687:Dehydroepiandrosterone / Q000627:therapeutic use; D004305:Dose-Response Relationship, Drug; D004414:Dyspareunia / Q000503:physiopathology / Q000628:therapy*; D004967:Estrogens / Q000627:therapeutic use; D000069582:Eszopiclone; D015444:Exercise; D005260:Female; D006197:Hair / Q000187:drug effects; D020249:Hormone Replacement Therapy; D019584:Hot Flashes / Q000209:etiology / Q000628:therapy*; D006801:Humans; D006993:Hypnotics and Sedatives / Q000627:therapeutic use; D007989:Libido / Q000187:drug effects; D008019:Life Style; D054327:Lubricants / Q000627:therapeutic use; D008593:Menopause / Q000502:physiology* / Q000523:psychology*; D008875:Middle Aged; D000451:Mineralocorticoid Receptor Antagonists / Q000627:therapeutic use; D008914:Minoxidil / Q000627:therapeutic use; D008517:Phytotherapy; D010879:Piperazines / Q000627:therapeutic use; D007319:Sleep Initiation and Maintenance Disorders / Q000209:etiology / Q000628:therapy; D013148:Spironolactone / Q000627:therapeutic use; D013739:Testosterone / Q000627:therapeutic use
chemical_list: D000276:Adjuvants, Immunologic; D000726:Androgen Antagonists; D000728:Androgens; D000928:Antidepressive Agents; D018687:Antidepressive Agents, Second-Generation; D053961:Azabicyclo Compounds; D004967:Estrogens; D006993:Hypnotics and Sedatives; D054327:Lubricants; D000451:Mineralocorticoid Receptor Antagonists; D010879:Piperazines; D016642:Bupropion; D013148:Spironolactone; D013739:Testosterone; D003687:Dehydroepiandrosterone; D017373:Cyproterone Acetate; D008914:Minoxidil; D000069582:Eszopiclone